Agnethe Eltoft

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 191 citations

Thrombosis, Tenecteplase Versus Alteplase, Cardiovascular Disease +15

Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

Melinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard et al. · The Lancet Neurology · 2022 · 87 citations · Full text

Non-contrast Ct, Interventional Neuroradiology, Cardiovascular Disease +12

Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø Study

Agnethe Eltoft, Kjell Arne Arntzen, Tom Wilsgaard et al. · Atherosclerosis · 2018 · 54 citations

Inflammation, Tromsø Study, Vascular Disease +11

C-reactive protein in atherosclerosis – A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study

Agnethe Eltoft, Kjell Arne Arntzen, John‐Bjarne Hansen et al. · Atherosclerosis · 2017 · 39 citations

Inflammation, Tromsø Study, Causal Factor +12

Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Andrew M. Demchuk et al. · The Lancet · 2025 · 37 citations · Full text